CareLit · DOI-Nachweis · Aktuelle Neurologie
Low rate of neutralising antibody formation to botulinum toxin type A in the course of treatment of primary axillary hyperhidrosis
DOI 10.1055/s-2005-919411
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Naumann, H Hamm, D Glaser, S Daggett, C Kumar, Y Weng, M Brin
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Hyperhidrosis is excessive sweating beyond that required to return body temperature to normal. Treatment of hyperhidrosis with botulinum toxin type A (BoNTA: BOTOX®, Allergan, Inc.) injections has been shown to be effective and well-tolerated. The development of neutralizing antibodies that interfere with clinical effectiveness is a risk of repeated exposure to BoNTA. Several factors can influence the de…
Zitieren
Zitierempfehlung
M Naumann, H Hamm, D Glaser, S Daggett, C Kumar, Y Weng, M Brin (2005) Low rate of neutralising antibody formation to botulinum toxin type A in the course of treatment of primary axillary hyperhidrosis. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919411
Mit CareLit weiterarbeiten